Safety Study Update – February 2025
We are excited to share an update about the ION283 Safety Study: the team at UTSW can continue enrolling patients. In December 2024, the first patient in the Lafora Disease Safety Study at the University of Texas Southwestern Medical Center (USTW) received their first dose of ION283, a treatment designed to halt disease progression. Last […]